Newspaper wrap-up 5-30-07: Bush taps Robert Zoellick to head World Bank

Eric Buscemi — Wed, 30 May 2007 09:04:00 EST

Filed under: Newspapers, Magazines, Pfizer (PFE)

MAJOR PAPERS:

The Wall Street Journal reported that President Bush picked former advisor Robert Zoellick to take over the World Bank from Paul Wolfowitz; Mr. Zoellick, now a vice chairman at Goldman Sachs Group Inc (NYSE: GS), was a trade representative and deputy secretary of state.
The Institutional Shareholder Service has advised shareholders of medical device maker Biomet Inc (NASDAQ: BMET) to turn down a $10.9B private equity deal for the company, according to the Wall Street Journal.
The Financial Times reported that the IntercontinentalExchange Inc (NYSE: ICE) has signed an exclusive deal with the CBOT Holdings Inc (NYSE: BOT), a move that could advance ICE's unsolicited bid for the Chicago Board of Trade.
Rather than focus on potential take-out targets, Barron's Online's "Weekday Trader" said that the smart bet for investors is to focus on companies with rising profits, cash flows and dividends, such as Loews Corp-Carolina Group (NYSE: CG) and Imperial Tobacco Group plc (NYSE: ITY), which boast free cash and dividends.

OTHER PAPERS:

Best Buy Co Inc (NYSE: BBY) is in talks with Vivek for a "foray" into India, the Economic Times reported.
The Washington Post reported that Nigeria filed criminal charges against Pfizer Inc (NYSE: PFE) over child deaths.

Newspaper wrap-up 5-30-07: Bush taps Robert Zoellick to head World Bank originally appeared on BloggingStocks on Wed, 30 May 2007 09:04:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

More nicotine in cigarettes but not in Marlboro

Melly Alazraki — Thu, 18 Jan 2007 18:15:00 EST

Filed under: Other Issues, Products and Services, Industry, Consumer Experience, Altria Group (MO)

Oh boy, oh boy. This is not what anyone wanted to hear, I'm sure; not investors, not smokers and definitely not the general public. But we did hear it. A research from Harvard University's School of Public Health found that manufacturers increased the level of nicotine in major-brand cigarettes by 11% between 1997 and 2005.

Regardless of how you look at it or how the manufacturers achieved it, the end result is the same -- far more addictive cigarettes.

While a similar study by Massachusetts Department of Public Health with similar results was already published in the summer, cigarette companies complained about the methods. The Harvard study took cigarette makers complaints into account and still confirmed the state's results. The average rate of nicotine increase was 1.1% per year from 1997 to 2005.

And which brands, might you ask, have the highest level of nicotine? It seems that Camel and Doral, made by R.J. Reynolds Tobacco Holdings, and Newport, made by Loews Corp (NYSE:LTR) Carolina Group's (NYSE:CG) Lorillard Tobacco have the highest levels. Marlboro, the best-selling brand made by Altria Group Inc.'s (NYSE:MO) subsidiary Philip Morris USA , showed no overall change.

Gregory Connolly, director of the Harvard School of Public Health's Tobacco Control Research Program, did say: "Our findings call into serious question whether the tobacco industry has changed at all in its pursuit of addicting smokers since signing the Master Settlement Agreement."

Now, if I'm an Altria shareholder, am I happy Phillip Morris didn't increase nicotine in its Marlboros, or am I unhappy the company isn't doing more (like its rivals) to hook smokers? Well, Altria shares closed down 0.7% while Carolina Group's shares closed up 0.9% today. Perhaps it's just a coincidence.

More nicotine in cigarettes but not in Marlboro originally appeared on BloggingStocks on Thu, 18 Jan 2007 18:15:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments